How much does a Neurocrine associate scientist make?
Vice presidents and executive officers at Neurocrine Biosciences command lucrative compensation packages disclosed through corporate proxy and regulatory filings. Total annual compensation for a vice president typically ranges from 1.5 million to over 6 million US dollars per fiscal year, heavily driven by multi-million-dollar equity incentive awards, stock options, and performance-based restricted stock units. While baseline cash salaries usually fall between 400,000 and 750,000 US dollars, comprehensive packages scale dramatically based on clinical pipeline milestones, commercial drug success, and long-term shareholder value creation.
Related FAQs
Nevada State Bank maintains a strong, favorable reputation as one of the state's longest-standing and most reliable financial institutions, serving consumer and commercial banking clients across the region.
Otsuka Pharmaceutical Co., Ltd., functioning as a major operating subsidiary under Otsuka Holdings Co., Ltd., is a globally renowned healthcare and pharmaceutical enterprise based in Tokyo, Japan.
Executive vice presidents and senior vice presidents leading functional departments at Neurocrine Biosciences receive elite remuneration packages aligned with the biopharmaceutical industry.
Equity partners and senior managing directors at private equity giants like The Carlyle Group earn multi-million-dollar annual compensation packages consisting of base salaries, carried interest distributions, and management fee allocations.
As of July 2026, the French cable and optical fiber manufacturer Nexans holds a market capitalization of approximately 635.01 billion Indian rupees. This figure places Nexans as a notable player within the global industrial sector.